Cash flow iRhythm Technologies, Inc.

Equities

IRTC

US4500561067

Advanced Medical Equipment & Technology

Market Closed - Nasdaq Other stock markets 21:00:00 20/09/2024 BST			5-day change	1st Jan Change
70.00 ^USD	-4.21%		-8.63%	-34.60%

09-11	IRhythm Technologies Secures Japanese Approval for EGC Monitoring Device	MT
09-04	IRhythm Technologies, Inc. Presents at Morgan Stanley 22nd Annual Global Healthcare Conference, Sep-04-2024 03:20 PM

2086f07efba3c8eda6193575c.GHcGvEnDGKRiAfbV5NrdBV4-f2rMtFOpe0BOYQytRuQ.Wi1Q9yCcUewsZ7WNhomoYwdJKD2DxhLzIjk8DVrCFKgqG1bmcIZQ7i9Rwg

Published financial data: IRHYTHM TECHNOLOGIES, INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2019	2020	2021	2022	2023
Revenues	215M	265M	323M	411M	493M
Total Revenues	215M	265M	323M	411M	493M
Cost of Goods Sold, Total	52.48M	70.28M	109M	129M	161M
Gross Profit	162M	195M	214M	282M	332M
Selling General & Admin Expenses, Total	180M	197M	275M	317M	370M
R&D Expenses	37.3M	41.33M	38.67M	46.61M	60.24M
Other Operating Expenses, Total	217M	239M	314M	364M	430M
Operating Income	-54.76M	-43.67M	-99.94M	-82.09M	-98.22M
Interest Expense, Total	-1.64M	-1.52M	-1.17M	-4.14M	-3.65M
Interest And Investment Income	1.01M	2.02M	1.76M	1.56M	6.35M
Net Interest Expenses	-632K	502K	590K	-2.58M	2.7M
Currency Exchange Gains (Loss)	-	-	-	-	-198K
Other Non Operating Income (Expenses)	-	-	-	-	-
EBT, Excl. Unusual Items	-55.39M	-43.17M	-99.35M	-84.67M	-95.71M
Restructuring Charges	-	-	-	-8.53M	-15.87M
Gain (Loss) On Sale Of Investments	884K	-430K	-1.64M	474K	-
Asset Writedown	-	-	-	-23.16M	-11.08M
Other Unusual Items	-	-	-	-	-
EBT, Incl. Unusual Items	-54.5M	-43.6M	-101M	-116M	-123M
Income Tax Expense	65K	229K	367K	269K	750K
Earnings From Continuing Operations	-54.57M	-43.83M	-101M	-116M	-123M
Net Income to Company	-54.57M	-43.83M	-101M	-116M	-123M
Net Income - (IS)	-54.57M	-43.83M	-101M	-116M	-123M
Net Income to Common Incl Extra Items	-54.57M	-43.83M	-101M	-116M	-123M
Net Income to Common Excl. Extra Items	-54.57M	-43.83M	-101M	-116M	-123M
Per Share Items
Net EPS - Basic	-2.16	-1.58	-3.46	-3.88	-4.04
Basic EPS - Continuing Operations	-2.16	-1.58	-3.46	-3.88	-4.04
Basic Weighted Average Shares Outstanding	25.27M	27.75M	29.33M	29.92M	30.53M
Net EPS - Diluted	-2.16	-1.58	-3.46	-3.88	-4.04
Diluted EPS - Continuing Operations	-2.16	-1.58	-3.46	-3.88	-4.04
Diluted Weighted Average Shares Outstanding	25.27M	27.75M	29.33M	29.92M	30.53M
Normalized Basic EPS	-1.37	-0.97	-2.12	-1.77	-1.96
Normalized Diluted EPS	-1.37	-0.97	-2.12	-1.77	-1.96
Supplemental Items
EBITDA	-51.31M	-36.77M	-90.1M	-68.69M	-94.07M
EBITA	-54.76M	-43.67M	-99.94M	-82.09M	-98.22M
EBIT	-54.76M	-43.67M	-99.94M	-82.09M	-98.22M
EBITDAR	-40.01M	-23.97M	-76.6M	-55.16M	-81.21M
Effective Tax Rate - (Ratio)	-0.12	-0.53	-0.36	-0.23	-0.61
Current Domestic Taxes	-	181K	223K	160K	401K
Current Foreign Taxes	68K	59K	150K	111K	349K
Total Current Taxes	68K	240K	373K	271K	750K
Deferred Foreign Taxes	-3K	-11K	-6K	-2K	-
Total Deferred Taxes	-3K	-11K	-6K	-2K	-
Normalized Net Income	-34.62M	-26.98M	-62.1M	-52.92M	-59.82M
Interest on Long-Term Debt	1.64M	1.52M	1.17M	4.14M	3.65M
Supplemental Operating Expense Items
Research And Development Expense From Footnotes	37.3M	41.33M	38.67M	46.61M	60.24M
Net Rental Expense, Total	11.3M	12.8M	13.5M	13.52M	12.86M
Imputed Operating Lease Interest Expense	1.82M	1.24M	1.05M	3.6M	2.88M
Imputed Operating Lease Depreciation	9.48M	11.56M	12.45M	9.92M	9.98M
Stock-Based Comp., COGS (Total)	658K	27K	1.9M	2.15M	3.6M
Stock-Based Comp., R&D Exp. (Total)	4.46M	7.73M	5.56M	6.98M	11.39M
Stock-Based Comp., SG&A Exp. (Total)	21.12M	33.76M	47.07M	48.61M	62.21M
Total Stock-Based Compensation	26.24M	41.52M	54.53M	57.74M	77.2M

Fiscal Period: December	2019	2020	2021	2022	2023
Assets
Cash And Equivalents	20.46M	88.63M	128M	78.83M	36.17M
Short Term Investments	120M	247M	112M	134M	97.59M
Total Cash And Short Term Investments	141M	335M	239M	213M	134M
Accounts Receivable, Total	23.87M	29.93M	46.43M	49.92M	61.48M
Total Receivables	23.87M	29.93M	46.43M	49.92M	61.48M
Inventory	4.04M	5.31M	10.27M	15.16M	13.97M
Prepaid Expenses	4.34M	7.36M	9.69M	10.56M	21.59M
Restricted Cash	-	-	-	-	-
Total Current Assets	173M	378M	306M	289M	231M
Gross Property Plant And Equipment	124M	133M	163M	172M	204M
Accumulated Depreciation	-7.63M	-13.85M	-22.7M	-35.22M	-50.5M
Net Property Plant And Equipment	117M	119M	141M	136M	153M
Long-term Investments	8.03M	-	-	-	3M
Goodwill	862K	862K	862K	862K	862K
Deferred Charges Long-Term	-	-	-	-	4.96M
Other Long-Term Assets, Total	7.94M	14.09M	16.05M	22.25M	40.08M
Total Assets	306M	512M	463M	448M	433M
Liabilities
Accounts Payable, Total	8.24M	4.36M	10.51M	7.52M	5.54M
Accrued Expenses, Total	29.91M	35.78M	48.5M	58.64M	75.91M
Current Portion of Long-Term Debt	1.94M	11.67M	11.67M	-	-
Current Portion of Leases	7.91M	8.17M	11.14M	13.03M	15.16M
Current Income Taxes Payable	-	-	-	2.39M	2.88M
Unearned Revenue Current, Total	1.25M	930K	3.05M	3.05M	3.31M
Other Current Liabilities	2.8M	4.76M	2.99M	4.46M	4.58M
Total Current Liabilities	52.07M	65.66M	87.85M	89.1M	107M
Long-Term Debt	32.99M	21.34M	9.69M	34.94M	34.95M
Long-Term Leases	85.75M	81.29M	85.21M	83.07M	79.72M
Other Non Current Liabilities	-	1.83M	697K	1.31M	1.01M
Total Liabilities	171M	170M	183M	208M	223M
Preferred Stock Convertible	-	-	-	-	-
Preferred Stock - Others	-	-	-	-	-
Total Preferred Equity	-	-	-	-	-
Common Stock, Total	25K	27K	27K	28K	31K
Additional Paid In Capital	396M	646M	686M	762M	856M
Retained Earnings	-260M	-305M	-406M	-522M	-646M
Comprehensive Income and Other	82K	11K	-61K	-396K	-112K
Total Common Equity	135M	342M	280M	240M	210M
Total Equity	135M	342M	280M	240M	210M
Total Liabilities And Equity	306M	512M	463M	448M	433M
Supplemental Items
ECS Total Shares Outstanding on Filing Date	26.8M	29.16M	29.51M	30.22M	30.98M
ECS Total Common Shares Outstanding	26.68M	29.02M	29.49M	30.19M	30.95M
Book Value / Share	5.07	11.77	9.48	7.94	6.79
Tangible Book Value	135M	341M	279M	239M	209M
Tangible Book Value Per Share	5.04	11.74	9.45	7.91	6.76
Total Debt	129M	122M	118M	131M	130M
Net Debt	-11.96M	-213M	-121M	-82.11M	-3.94M
Debt Equivalent Oper. Leases	90.4M	102M	108M	108M	103M
Account Code - Inventory Valuation	8	5	5	5	5
Inventories - Raw Materials, Total	1.57M	2.47M	5.1M	9.34M	6.3M
Inventories - Finished Goods, Total	2.46M	2.84M	5.17M	5.82M	7.67M
Machinery, Total	10.22M	10.47M	11.56M	11.34M	13.93M
Full Time Employees	997	1.16K	1.7K	1.79K	2K
Accumulated Allowance for Doubtful Accounts (Supple)	9.05M	12.71M	14.01M	18.48M	20.29M

Fiscal Period: December	2019	2020	2021	2022	2023
Net Income	-54.57M	-43.83M	-101M	-116M	-123M
Depreciation & Amortization - CF	3.44M	6.9M	9.84M	19.61M	9.94M
Depreciation & Amortization, Total	3.44M	6.9M	9.84M	19.61M	9.94M
Amortization of Deferred Charges, Total - (CF)	37K	-	-	-	12.2M
(Gain) Loss From Sale Of Asset	-	-	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-884K	430K	1.64M	-474K	-5.04M
Asset Writedown & Restructuring Costs	-	-	-	23.16M	11.08M
Stock-Based Compensation (CF)	26.24M	41.52M	54.53M	57.74M	77.2M
Provision and Write-off of Bad Debts	24.65M	31.43M	37.07M	58.35M	69.63M
Other Operating Activities, Total	8.95M	6.03M	6.75M	264K	337K
Change In Accounts Receivable	-28.72M	-37.96M	-53.57M	-61.84M	-81.19M
Change In Inventories	-1.97M	-1.39M	-4.96M	-5.11M	979K
Change In Accounts Payable	5.6M	-3.88M	6.14M	-2.99M	-1.97M
Change in Unearned Revenues	28K	-321K	2.12M	2K	255K
Change in Other Net Operating Assets	-4.67M	-12.69M	4.05M	4.43M	-20.11M
Cash from Operations	-21.86M	-13.76M	-37.75M	-23.01M	-50.1M
Capital Expenditure	-20.46M	-13.55M	-28.07M	-29.83M	-40.42M
Investment in Marketable and Equity Securities, Total	-68.82M	-119M	133M	-22.6M	39.22M
Other Investing Activities, Total	-	-	-	-	-
Cash from Investing	-89.27M	-132M	105M	-52.43M	-1.21M
Long-Term Debt Issued, Total	-	-	-	35M	-
Total Debt Issued	-	-	-	35M	-
Long-Term Debt Repaid, Total	-	-1.94M	-11.67M	-21.39M	-
Total Debt Repaid	-	-1.94M	-11.67M	-21.39M	-
Issuance of Common Stock	117M	226M	8.94M	13.18M	8.82M
Repurchase of Common Stock	-5.29M	-10.01M	-25.85M	-	-
Issuance of Preferred Stock	-	-	-	-	-
Other Financing Activities, Total	-	-	-	-77K	-
Cash from Financing	112M	214M	-28.58M	26.72M	8.82M
Foreign Exchange Rate Adjustments	-	-	-	-	-169K
Net Change in Cash	439K	68.17M	38.93M	-48.73M	-42.66M
Supplemental Items
Cash Interest Paid	1.64M	1.5M	1.19M	3.32M	2.96M
Cash Income Tax Paid (Refund)	-	-	-	287K	1.13M
Levered Free Cash Flow	-20.4M	-129K	-31.46M	-4.59M	-10.02M
Unlevered Free Cash Flow	-19.41M	820K	-30.73M	-2.01M	-7.74M
Change In Net Working Capital	-5.58M	6.75M	4.57M	-1.78M	5.27M
Net Debt Issued / Repaid	-	-1.94M	-11.67M	13.61M	-

Fiscal Period: December	2019	2020	2021	2022	2023
Profitability
Return on Assets	-16.15	-6.67	-12.82	-11.26	-13.93
Return on Total Capital	-19.5	-7.5	-14.5	-13.36	-17.27
Return On Equity %	-58.19	-18.38	-32.64	-44.73	-54.86
Return on Common Equity	-58.19	-18.38	-32.64	-44.73	-54.86
Margin Analysis
Gross Profit Margin %	75.54	73.5	66.16	68.54	67.35
SG&A Margin	83.67	74.38	85.14	77.17	75.05
EBITDA Margin %	-23.91	-13.87	-27.91	-16.72	-19.09
EBITA Margin %	-25.52	-16.47	-30.96	-19.98	-19.94
EBIT Margin %	-25.52	-16.47	-30.96	-19.98	-19.94
Income From Continuing Operations Margin %	-25.43	-16.53	-31.4	-28.27	-25.05
Net Income Margin %	-25.43	-16.53	-31.4	-28.27	-25.05
Net Avail. For Common Margin %	-25.43	-16.53	-31.4	-28.27	-25.05
Normalized Net Income Margin	-16.13	-10.18	-19.24	-12.88	-12.14
Levered Free Cash Flow Margin	-9.51	-0.05	-9.74	-1.12	-2.03
Unlevered Free Cash Flow Margin	-9.05	0.31	-9.52	-0.49	-1.57
Asset Turnover
Asset Turnover	1.01	0.65	0.66	0.9	1.12
Fixed Assets Turnover	3.41	2.25	2.49	2.97	3.4
Receivables Turnover (Average Receivables)	9.83	9.86	8.46	8.53	8.85
Inventory Turnover (Average Inventory)	17.21	15.03	14.02	10.17	11.05
Short Term Liquidity
Current Ratio	3.32	5.75	3.48	3.24	2.15
Quick Ratio	3.16	5.56	3.25	2.95	1.82
Operating Cash Flow to Current Liabilities	-0.42	-0.21	-0.43	-0.26	-0.47
Days Sales Outstanding (Average Receivables)	37.13	37.13	43.17	42.79	41.27
Days Outstanding Inventory (Average Inventory)	21.21	24.35	26.03	35.89	33.04
Average Days Payable Outstanding	35.28	32.25	23.77	24.52	14.92
Cash Conversion Cycle (Average Days)	23.07	29.23	45.43	54.16	59.38
Long Term Solvency
Total Debt/Equity	94.97	35.85	42.11	54.64	61.79
Total Debt / Total Capital	48.71	26.39	29.63	35.33	38.19
LT Debt/Equity	87.69	30.04	33.95	49.21	54.58
Long-Term Debt / Total Capital	44.98	22.12	23.89	31.82	33.73
Total Liabilities / Total Assets	55.78	33.24	39.63	46.5	51.49
EBIT / Interest Expense	-33.33	-28.75	-85.49	-19.84	-26.91
EBITDA / Interest Expense	-24.35	-15.78	-65.53	-13.33	-22.25
(EBITDA - Capex) / Interest Expense	-36.8	-24.7	-89.54	-20.54	-33.32
Total Debt / EBITDA	-3.21	-5.11	-1.54	-2.38	-1.6
Net Debt / EBITDA	0.3	8.87	1.59	1.49	0.05
Total Debt / (EBITDA - Capex)	-2.13	-3.26	-1.12	-1.54	-1.07
Net Debt / (EBITDA - Capex)	0.2	5.67	1.16	0.97	0.03
Growth Over Prior Year